Health: pharmaceuticals; insulin production program; establish. Amends sec. 9 of 1984 PA 270 (MCL 125.2009) & adds ch. 8F.
This bill creates a new state program to partner with a private company for manufacturing and distributing insulin within Michigan to address rising costs and improve access for residents with diabetes. The state will provide up to $50 million in grants to help a selected contractor build or renovate facilities, provided the company owns the property and prioritizes creating local jobs. The program specifically seeks a partner that can produce both long-acting and rapid-acting insulin and must secure approval from the federal government regarding foreign investment before proceeding.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
Governor
Introduced Jul 18, 2023
Last action May 22, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
6
Key actions
1
Committee
3
May 22, 2024
Committee
referred to second reading
lower
May 22, 2024
Lower · Passed
reported with recommendation with substitute (H-2)
lower
Jul 18, 2023
Committee
referred to Committee on Health Policy
lower
Jul 18, 2023
Introduced
introduced by Representative Curtis VanderWall
lower
1 primary · 6 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 4890
Scope: MI
Hi! I can help you understand HB 4890. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline